Table 1 Representative scanning sequences and parameters
3.0-T Achieva, Philips (Saitama Medical University International Medical Center) | ||||||
Sequence | TR/TE (msec) | Matrix | NEX | FOV (cm2) | Slice thickness (mm) | Flip Angle (degree) |
T2WI | 3546–5598/100 | 352 × 272 | 2 | 28 × 32 | 5–6 | 90 |
T1WI | 180–448/1.15–2.3 | 224 × 180 | 2 | 28 × 32 | 5–6 | 75 |
DWI | 6250–8750/75 | 112 × 168 | 2 | 32 × 36 | 5–6 | 90 |
(b = 0, 500, 1,000 s/mm2) | ||||||
CE-MRI | 3.1–3.4/1.54–1.65 | 256 × 181 | 1 | 28 × 32 | 3–4 | 12 |
(multiphasic 3D gradient echo sequence (eTHRIVE); 35, 65, 95, and 125 s after the intravenous injection of 0.1 mmol/kg meglumine gadoterate) | ||||||
3.0-T Skyra, Siemens Healthcare (Tokyo Metropolitan Komagome Hospital) | ||||||
Sequence | TR/TE (msec) | Matrix | NEX | FOV (cm2) | Slice thickness (mm) | Flip Angle (degree) |
T2WI | 3800–4200/87–91 | 384 × 269 | 1 | 38 × 38 | 5–6 | 120 |
T1WI | 520–617/11–13 | 384 × 269 | 1 | 38 × 38 | 5–6 | 120 |
DWI | 4000–5700/69–70 | 128 × 59 | 1 | 16 × 26 | 5–6 | 90 |
(b = 0, 1,000 s/mm2) | ||||||
CE-MRI | 3.62–3.72/1.3 | 256 × 151 | 1 | 17 × 26 | 3–4 | 10 |
(multiphasic 3D gradient echo sequence (t1_vibe_fs_ce); 30, 60, 90, and 120 s after the intravenous injection of 0.1 mmol/kg meglumine gadoterate) | ||||||